How New Technologies Can Improve Compliance In Pharmaceutical and Biotech Manufacturing


In today’s pharmaceutical and biotechnology manufacturing environments, compliance has taken on new meaning. It once implied a system of warnings that required attention. Today, the Food and Drug Administration (FDA) is demanding a new focus on compliance. Recent headlines reveal continuing industry problems and new efforts by the FDA to reduce them. And when you look beneath the regulation jargon, there are new opportunities to improve manufacturing efficiencies as well as compliance in ways that benefit the bottom line rather than cut into it. This paper explores the recent regulatory and industry changes that place new demands on manufacturers today. Then, it looks at newer technology solutions that exist to help navigate the current and future needs of life sciences manufacturing.